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An expanding body of evidence dem-onstrates that cells undergoing apop-
tosis send out a selection of molecular 
navigational signals including proteins, 
lipids and nucleotides that serve to recruit 
phagocytes to the dying targets, which 
are subsequently engulfed and removed. 
This homeostatic process is essentially 
non-phlogistic, contrasting markedly with 
the acute inflammatory responses elicited 
in phagocytes by damaging or infectious 
agents. The “professional” scavengers of 
apoptotic cells are mononuclear phago-
cytes—the macrophages—and sites of 
high-rate apoptosis are clearly character-
ized by macrophages associated with the 
apoptotic cells. By contrast, members of the 
other class of professional phagocytes—
the granulocytes—are not recruited to 
sites of apoptosis as a direct consequence 
of the cell-death program. Indeed, recent 
work indicates that apoptotic cells release 
a mixture of migratory cues to leukocytes 
in order to selectively attract mononuclear 
phagocytes but not granulocytes through 
functional balancing of positive and 
negative signals. Here we discuss these 
molecular mechanisms that not only serve 
as migratory cues but also may activate 
responding phagocytes to engulf apop-
totic cells effectively. Finally, we speculate 
upon new therapeutic opportunities these 
mechanisms offer for a range of pathologi-
cal conditions, including inflammatory 
disorders and cancer.
Introduction
Inherent in the cell-death program apop-
tosis are cellular responses to the program, 
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not least of which are the responses of 
phagocytes that locate, recognize, engulf 
and degrade dying cells. The efficiency 
and importance of these phagocytic 
responses is illustrated by the paucity of 
readily detectable apoptotic cells in tis-
sues and by the pathological consequences 
of persistent apoptotic cells, particularly 
illustrated in animal models in which 
specific pathways in these responses are 
blocked.1-10 Recently, knowledge of the 
molecular mechanisms underlying the 
“scent” of cell death11—the mechanisms 
by which phagocytes initially locate and 
navigate towards apoptotic cells—has 
increased substantially. Predictably, as the 
molecular complexity of the chemoattrac-
tive mechanisms unfolds, additional ques-
tions arise, some of which we will address 
here. Specifically, given that phagocyte 
chemoattractant moieties released by 
apoptotic cells have potential to act on 
both groups of professional phagocytes—
both the mononuclear phagocytes and the 
granulocytes—how is it that only mono-
nuclear phagocytes are actively recruited 
to locations of apoptosis? Furthermore, 
since the chemoattractants of phagocytes 
have multifunctional properties, are these 
important in the apoptotic-cell clearance 
process? Finally, can these migratory 
mechanisms be targeted therapeutically?
Phagocyte Chemoattractant  
Signals Coupled to Clearance  
of Dead and Dying Cells
We have recently rationalized three main 
phases in the clearance of apoptotic cells: 
recognition, response and removal.10 
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In this way, the phagocyte response could 
be pivotal in certain circumstances to the 
fundamental fates of cell death or survival.
While several studies associate che-
moattractant release with the activation 
of the apoptosis program and demonstrate 
active release prior to plasma membrane 
breakdown (reviewed in refs. 14, 15 and 
17), such investigations tend not to dif-
ferentiate between processes occurring 
in stressed cells that lead to apoptosis 
and mechanisms activated specifically in 
apoptosis. Both situations are likely to 
have significant biological value. Other 
studies provide compelling arguments 
for a mechanistic association of chemoat-
tractant release and the activation of the 
apoptosis machinery by demonstrating 
that effector proteases in the apoptosis 
program act on key substrates that con-
sequently mediate release of chemotactic 
molecules. Thus, Lauber and colleagues 
showed that release of the chemotac-
tic lipid LPC from apoptotic cells is 
dependent on the activation of phospho-
lipase A2 (which hydrolyses membrane- 
associated phosphatidylcholine to produce 
LPC) by the apoptotic effector protease, 
caspase-3.13 More recently, Ravichandran’s 
group demonstrated that the release of 
nucleotides in apoptosis occurs via the 
plasma membrane channel pannexin 1 
(PANX1). Significantly, PANX1 was 
found to be a target in apoptosis for the 
effector proteases caspase-3 and caspase-7 
with a specific caspase cleavage site in the 
channel being required for its regulation 
during the apoptosis program.16
Specific and Combinatorial 
 Signals for Selective Attraction  
of Mononuclear Phagocytes
Regardless of whether chemotactic factor 
release occurs as a specific consequence of 
activation of the apoptosis machinery or 
as a result of pre-apoptotic stress (both 
are biologically relevant), how is selective 
attraction of mononuclear phagocytes 
ultimately achieved? This is an important 
consideration because it is clear that fac-
tors which have the capability to effect 
attraction of both types of professional 
phagocytic leukocytes—mononuclear and 
polymorphonuclear (granulocytes)—are 
released from apoptotic cells. For example, 
molecules have additional functions of rel-
evance to the clearance process (response 
and removal phases)? (4) Which mol-
ecules predominate in supporting clear-
ance of dying and dead cells in normal or 
pathological processes in vivo?
Phagocyte  Chemoattractants 
 Released from Stressed, 
 Apoptotic and Dead Cells
An extensive array of small molecules and 
macromolecules such as heat shock pro-
teins, nucleotides and formylated peptides 
that have the potential to act as phagocyte 
chemoattractants are released from cells 
whose plasma membranes have lost integ-
rity.20-23 Such cells would include those 
that undergo primary necrosis and those 
that reach the post-apoptotic state—a 
situation that occurs in pathological con-
ditions and also occurs frequently in vitro 
when, as is usually the case with cell cul-
tures, apoptotic cells persist because of the 
absence of effective phagocytic clearance 
mechanisms. Persistence of apoptotic cells 
does not occur under normal circum-
stances in vivo, although can occur when 
molecular clearance pathways are blocked 
and has been linked to autoimmune dis-
ease (reviewed in ref. 8).
Of importance to the biological value 
of apoptosis and to the phagocytic clear-
ance process is the essence of speed: phago-
cytes responding at a distance require 
time to sense and locate apoptotic cells. 
To this end, cells committed to undergo 
apoptosis would be expected to produce 
chemoattractant/pro-migratory signals 
actively at an early stage in the process, 
in concert with the molecular machin-
ery of the apoptosis program. Indeed, it 
seems likely that stressed cells that are not 
of necessity committed to undergo apop-
tosis—but rather are pre-apoptotic, with 
commitment to the cell-death program a 
fate decision still to be concluded—may 
also send out earlier navigational signals 
to phagocytes. Since phagocytes have the 
ability either to promote cell death or cell 
survival,24-27 such signals (perhaps depend-
ing additionally on phagocyte activation 
properties of migration-controlling fac-
tors, as we discuss later) could conceivably 
either promote or prevent commitment to 
apoptosis in pre-apoptotic, stressed cells. 
Acting early in the recognition phase 
are the molecules that signal the loca-
tion of the apoptotic cell to phagocytes. 
Immediately juxtaposed cells of a variety 
of different lineages—including for exam-
ple, fibroblasts, epithelial cells and myo-
cytes—can phagocytose their apoptotic 
neighbors and although little is yet known 
of the signaling processes underlying such 
“non-professional” phagocytic responses, 
(cf. ELMO1 in clearance of apoptotic 
germ cells in the testis12), it is assumed 
that the early migratory responses are 
generally not required. It is conceivable, 
however, that additional functional (e.g., 
pro-phagocytic, vide infra) effects of the 
same chemoattractants as those required 
for recruitment of professional phagocytes 
may be required for the response phase of 
non-professional phagocytes of apoptotic 
cells. We will consider here the responses 
of the professional phagocytes, since these 
are invariably found at sites of apoptosis 
in multiple tissues, embryonic and adult.
Over recent years, the spectrum of che-
moattractants produced by apoptotic cells 
to activate directed migration of mononu-
clear phagocytes has grown markedly. The 
best characterized players now include the 
lipids lysophosphosphatidylcholine (LPC) 
and sphingosine-1-phosphate (S1P),13,14 
the nucleotides, ATP and UTP,15,16 as 
well as the classical protein chemokines, 
CX
3
CL1 (fractalkine) and CCL2 (MCP-
1).17,18 All of these molecules appear to act 
through phagocyte-associated G-protein-
coupled receptors—G2A (for LPC), P2Y
2
 
(for nucleotides), CX
3
CR1 (for CX
3
CL1), 
CCR2 (for CCL2) and ill-defined GPCR 
(for S1P).13-15,17,18 Other phagocyte che-
moattractant proteins released from apop-
totic cells include the covalent dimer of 
ribosomal protein S19, endothelial mono-
cyte-activating polypeptide II (EMAP II), 
thrombospondin 1, TGFβ and annexin I 
(reviewed in refs. 9 and 19).
Several important questions arise in 
connection with the attributes of such a 
panoply of potential chemoattractants: 
(1) Which molecules are actively released 
from stressed (pre-apoptotic) cells, dying 
(apoptotic) cells or passively released 
from dead (lysed, necrotic, post-apoptotic 
cells)? (2) Which ones are specifically che-
motactic for (or enable directed migration 
of) mononuclear phagocytes? (3) Do these 
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other potential candidate molecules that 
could fulfill this role. For example, the 
laminin-related neural guidance protein, 
Netrin-1 functionally inhibits neutrophil 
recruitment through attenuation of trans-
epithelial migration.33,34 Furthermore, 
depending on the local concentrations 
and site of generation, agents that elevate 
cAMP (especially the prostaglandins 
PGE
2
, PGI
2
 and PGD
2
) in neutrophils 
may dampen neutrophil recruitment and 
activation.35-38 Other lipids demonstrated, 
especially by Serhan and colleagues, to 
play important roles in the resolution of 
inflammation are the lipoxins, resolvins 
and protectins.39-41 These lipids generated 
and released during different phases of 
the resolving inflammatory response have 
an intriguing biological profile that are 
likely important in selective recruitment 
and activation of specific leukocyte sub-
types. Furthermore, it has been well docu-
mented that apoptotic cells that interact 
with macrophages can cause the phago-
cytes to switch from a pro-inflammatory 
to a more anti-inflammatory phenotype. 
Consequently, there is a downregulation 
of pro-inflammatory mediator generation 
release lactoferrin in response to apoptotic 
stimuli. Significantly, we showed that 
lactoferrin binds to specific receptors on 
granulocytes and markedly inhibits their 
ability to migrate towards numerous che-
moattractants in vitro or to respond to 
acute inflammatory stimuli in vivo.30,31 By 
negatively regulating granulocyte activa-
tion and migratory responses, apoptotic 
cells are thus able to deploy a barrage of 
leukocyte pro-migratory molecules—
including those that may otherwise recruit 
granulocytes—in pursuit of macrophage 
attraction (Fig. 1).
Our studies indicated that other nega-
tive regulators of granulocyte migration 
are also likely to be produced by apoptotic 
cells because residual migration inhibitory 
activity was observed in the absence of 
lactoferrin or when its function had been 
neutralized.30 Indeed, although to our 
knowledge no other specific negative reg-
ulators of neutrophil recruitment released 
from apoptotic cells have been directly 
implicated, (although annexin 1 may be a 
candidate in this respect in view of its abil-
ity to inhibit neutrophil-endothelial bind-
ing under conditions of flow32) there are 
ATP is known to act as a chemoattrac-
tant (or at least an activator of migration) 
for both granulocytes and mononuclear 
phagocytes but granulocytes are not 
recruited to sites of apoptosis to medi-
ate cell clearance whereas mononuclear 
phagocytes are. Similar arguments can 
be made for the cytokine-like polypep-
tide EMAP II which also has functional 
activity in promoting granulocyte che-
moattraction.11,28,29 Recent work suggests 
a possible mechanism of selective recruit-
ment of professional phagocytes whereby 
release of multiple regulators of migra-
tion by apoptotic cells functionally ‘filters 
out’ granulocytes resulting in preferential 
mononuclear phagocyte attraction (Fig. 1). 
The paradigm for this mechanism that 
comprises a balance of positive and nega-
tive migratory cues (“Find Me” versus 
“Keep Out” signals11) lies in the develop-
ing nervous system. Thus, we suggest that 
a key molecule in this filtration process 
is lactoferrin—a pleiotropic protein with 
anti-inflammatory properties which we 
reported to be released from apoptotic 
cells of multiple cell lineages.30 Even pri-
mary human lymphocytes were found to 
Figure 1. Leukocyte migratory factors released from apoptotic cells: “Keep out” and “Find Me” signals. Selective attraction of mononuclear phago-
cytes to sites of apoptosis is proposed to result from a balance between positive signals that attract leukocytes (or specifically mononuclear phago-
cytes) and negative, anti-inflammatory signals that inhibit granulocyte migration. Four categories of signaling factors are proposed: (1) factors that 
promote migration of both mononuclear phagocytes and granulocytes (e.g., AtP, eMAP ii); (2) factors that promote selective migration of mono-
nuclear phagocytes (e.g., CX3CL1, CCL2); (3) factors inhibiting granulocyte migration (none yet defined as released from apoptotic cells but candidates 
include lipoxins and netrin-1); (4) factors that both attract mononuclear phagocytes but inhibit granulocyte migration (e.g., lactoferrin). the promoters 
of monocyte/macrophage attraction may also prepare these professional phagocytes for enhanced clearance of apoptotic cells. Adapted from refer-
ence 11.
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and release (e.g., IL-1, IL-8 and TNFα) 
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anti-inflammatory potential (including 
IL-10, TGFβ and PGE
2
).42,43 This change 
in the inflammatory milieu per se may 
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3
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v
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tion as a chemoattractant for mononuclear 
phagocytes46 and it will be important to 
determine whether this highly pleiotropic 
www.landesbioscience.com Cell Adhesion & Migration 297
39. Serhan CN. Novel lipid mediators and resolution 
mechanisms in acute inflammation: to resolve or not? 
Am J Pathol 2010; 177:1576-91.
40. Serhan CN, Brain SD, Buckley CD, Gilroy DW, 
Haslett C, O’Neill LA, et al. Resolution of inflamma-
tion: state of the art, definitions and terms. FASEB J 
2007; 21:325-32.
41. Serhan CN, Chiang N, Van Dyke TE. Resolving 
inflammation: dual anti-inflammatory and pro-res-
olution lipid mediators. Nat Rev Immunol 2008; 
8:349-61.
42. Voll RE, Herrmann M, Roth EA, Stach C, Kalden 
JR, Girkontaite I. Immunosuppressive effects of 
apoptotic cells. Nature 1997; 390:350-1.
43. Fadok VA, Bratton DL, Konowal A, Freed PW, 
Westcott JY, Henson PM. Macrophages that have 
ingested apoptotic cells in vitro inhibit proinflam-
matory cytokine production through autocrine/para-
crine mechanisms involving TGFβ, PGE2 and PAF. 
J Clin Invest 1998; 101:890-8.
44. Miksa M, Amin D, Wu R, Ravikumar TS, Wang 
P. Fractalkine-induced MFG-E8 leads to enhanced 
apoptotic cell clearance by macrophages. Mol Med 
2007; 13:553-60.
45. Marques-da-Silva C, Burnstock G, Ojcius DM, 
Coutinho-Silva R. Purinergic receptor agonists mod-
ulate phagocytosis and clearance of apoptotic cells in 
macrophages. Immunobiology 2011; 216:1-11.
46. de la Rosa G, Yang D, Tewary P, Varadhachary A, 
Oppenheim JJ. Lactoferrin acts as an alarmin to 
promote the recruitment and activation of APCs 
and antigen-specific immune responses. J Immunol 
2008; 180:6868-76.
47. Kai K, Komine K, Komine Y, Kuroishi T, Kozutsumi 
T, Kobayashi J, et al. Lactoferrin stimulates A 
Staphylococcus aureus killing activity of bovine phago-
cytes in the mammary gland. Microbiol Immunol 
2002; 46:187-94.
29. Chen Y, Corriden R, Inoue Y, Yip L, Hashiguchi N, 
Zinkernagel A, et al. ATP release guides neutrophil 
chemotaxis via P2Y2 and A3 receptors. Science 2006; 
314:1792-5.
30. Bournazou I, Pound JD, Duffin R, Bournazos S, 
Melville LA, Brown SB, et al. Apoptotic human cells 
inhibit migration of granulocytes via release of lacto-
ferrin. J Clin Invest 2009; 119:20-32.
31. Bournazou I, Mackenzie KJ, Duffin R, Rossi AG, 
Gregory CD. Inhibition of eosinophil migration by 
lactoferrin. Immunol Cell Biol 2010; 88:220-3.
32. Hayhoe RP, Kamal AM, Solito E, Flower RJ, Cooper 
D, Perretti M. Annexin 1 and its bioactive peptide 
inhibit neutrophil-endothelium interactions under 
f low: indication of distinct receptor involvement. 
Blood 2006; 107:2123-30.
33. Ly NP, Komatsuzaki K, Fraser IP, Tseng AA, Prodhan 
P, Moore KJ, et al. Netrin-1 inhibits leukocyte migra-
tion in vitro and in vivo. Proc Natl Acad Sci USA 
2005; 102:14729-34.
34. Rosenberger P, Schwab JM, Mirakaj V, Masekowsky 
E, Mager A, Morote-Garcia JC, et al. Hypoxia-
inducible factor-dependent induction of netrin-1 
dampens inf lammation caused by hypoxia. Nat 
Immunol 2009; 10:195-202.
35. Kunkel SL, Thrall RS, Kunkel RG, McCormick JR, 
Ward PA, Zurier RB. Suppression of immune com-
plex vasculitis in rats by prostaglandin. J Clin Invest 
1979; 64:1525-9.
36. Kunkel SL, Ogawa H, Conran PB, Ward PA, Zurier 
RB. Suppression of acute and chronic inflamma-
tion by orally administered prostaglandins. Arthritis 
Rheum 1981; 24:1151-8.
37. Pons F, Williams TJ, Kirk SA, McDonald F, Rossi 
AG. Pro-inf lammatory and anti-inf lammatory 
effects of the stable prostaglandin D2 analogue, ZK 
118.182. Eur J Pharmacol 1994; 261:237-47.
38. Rampart M, Williams TJ. Polymorphonuclear leu-
kocyte-dependent plasma leakage in the rabbit skin 
is enhanced or inhibited by prostacyclin, depending 
on the route of administration. Am J Pathol 1986; 
124:66-73.
18. Kobara M, Sunagawa N, Abe M, Tanaka N, Toba H, 
Hayashi H, et al. Apoptotic myocytes generate mono-
cyte chemoattractant protein-1 and mediate macro-
phage recruitment. J Appl Physiol 2008; 104:601-9.
19. Peter C, Wesselborg S, Herrmann M, Lauber K. 
Dangerous attraction: phagocyte recruitment and 
danger signals of apoptotic and necrotic cells. 
Apoptosis 2010; 15:1007-28.
20. Foell D, Wittkowski H, Roth J. Mechanisms of dis-
ease: a ‘DAMP’ view of inflammatory arthritis. Nat 
Clin Pract Rheumatol 2007; 3:382-90.
21. Iyer SS, Pulskens WP, Sadler JJ, Butter LM, Teske 
GJ, Ulland TK, et al. Necrotic cells trigger a sterile 
inflammatory response through the Nlrp3 inflamma-
some. Proc Natl Acad Sci USA 2009; 106:20388-93.
22. McDonald B, Pittman K, Menezes GB, Hirota SA, 
Slaba I, Waterhouse CC, et al. Intravascular danger 
signals guide neutrophils to sites of sterile inflamma-
tion. Science 2010; 330:362-6.
23. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger 
W, et al. Circulating mitochondrial DAMPs cause 
inf lammatory responses to injury. Nature 2010; 
464:104-7.
24. Duffield JS, Erwig LP, Wei XQ, Liew FY, Rees AJ, 
Savill JS. Activated macrophages direct apoptosis and 
suppress mitosis of mesangial cells. J Immunol 2000; 
164:2110-9.
25. Hoeppner DJ, Hengartner MO, Schnabel R. 
Engulfment genes cooperate with ced-3 to promote 
cell death in Caenorhabditis elegans. Nature 2001; 
412:202-6.
26. Reddien PW, Cameron S, Horvitz HR. Phagocytosis 
promotes programmed cell death in C. elegans. 
Nature 2001; 412:198-202.
27. Ogden CA, Pound JD, Batth BK, Owens S, 
Johannessen I, Wood K, et al. Enhanced apoptotic 
cell clearance capacity and B cell survival factor pro-
duction by IL-10-activated macrophages: implica-
tions for Burkitt’s lymphoma. J Immunol 2005; 
174:3015-23.
28. Kao J, Ryan J, Brett G, Chen J, Shen H, Fan YG, et al. 
Endothelial monocyte-activating polypeptide II. A novel 
tumor-derived polypeptide that activates host-response 
mechanisms. J Biol Chem 1992; 267:20239-47.
